Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Wieland

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Opinion in Biotechnology|July 20, 2010
Ligand-dependent regulatory RNA parts for Synthetic Biology in eukaryotesMarkus Wieland, Martin Fussenegger
Annual Review of Chemical and Biomolecular Engineering|April 4, 2012
Engineering molecular circuits using synthetic biology in mammalian cellsMarkus Wieland, Martin Fussenegger
Advanced Drug Delivery Reviews|June 23, 2012
Reprogrammed cell delivery for personalized medicineMarkus Wieland, Martin Fussenegger
Angewandte Chemie (International Ed. in English)|July 28, 2006
Turning inhibitors into activators: a hammerhead ribozyme controlled by a guanine quadruplexMarkus Wieland, Jörg S Hartig
Chemistry & Biology|July 28, 2007
RNA quadruplex-based modulation of gene expressionMarkus Wieland, Jörg S Hartig
Nature Protocols|October 31, 2009
Investigation of mRNA quadruplex formation in Escherichia coliMarkus Wieland, Jörg S Hartig
Chembiochem : a European Journal of Chemical Biology|July 8, 2008
Artificial riboswitches: synthetic mRNA-based regulators of gene expressionMarkus Wieland, Jörg S Hartig
Angewandte Chemie (International Ed. in English)|February 14, 2008
Improved aptazyme design and in vivo screening enable riboswitching in bacteriaMarkus Wieland, Jörg S Hartig
Metabolic Engineering|July 5, 2011
Smart medication through combination of synthetic biology and cell microencapsulationSimon Ausländer, Markus Wieland, Martin Fussenegger
Methods (San Diego, Calif.)|February 7, 2012
Engineering of ribozyme-based riboswitches for mammalian cellsMarkus Wieland, David Ausländer, Martin Fussenegger
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Opinion in Biotechnology|July 20, 2010
Ligand-dependent regulatory RNA parts for Synthetic Biology in eukaryotesMarkus Wieland, Martin Fussenegger
Annual Review of Chemical and Biomolecular Engineering|April 4, 2012
Engineering molecular circuits using synthetic biology in mammalian cellsMarkus Wieland, Martin Fussenegger
Advanced Drug Delivery Reviews|June 23, 2012
Reprogrammed cell delivery for personalized medicineMarkus Wieland, Martin Fussenegger
Angewandte Chemie (International Ed. in English)|July 28, 2006
Turning inhibitors into activators: a hammerhead ribozyme controlled by a guanine quadruplexMarkus Wieland, Jörg S Hartig
Chemistry & Biology|July 28, 2007
RNA quadruplex-based modulation of gene expressionMarkus Wieland, Jörg S Hartig
Nature Protocols|October 31, 2009
Investigation of mRNA quadruplex formation in Escherichia coliMarkus Wieland, Jörg S Hartig
Chembiochem : a European Journal of Chemical Biology|July 8, 2008
Artificial riboswitches: synthetic mRNA-based regulators of gene expressionMarkus Wieland, Jörg S Hartig
Angewandte Chemie (International Ed. in English)|February 14, 2008
Improved aptazyme design and in vivo screening enable riboswitching in bacteriaMarkus Wieland, Jörg S Hartig
Metabolic Engineering|July 5, 2011
Smart medication through combination of synthetic biology and cell microencapsulationSimon Ausländer, Markus Wieland, Martin Fussenegger
Methods (San Diego, Calif.)|February 7, 2012
Engineering of ribozyme-based riboswitches for mammalian cellsMarkus Wieland, David Ausländer, Martin Fussenegger
Pageof 3